MENU
+Compare
GIFLF
Stock ticker: OTC
AS OF
Jul 23 closing price
Price
$13.90
Change
+$2.45 (+21.40%)
Capitalization
7.89B

GIFLF Grifols Sa Forecast, Technical & Fundamental Analysis

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

GIFLF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for GIFLF with price predictions
Feb 03, 2026

GIFLF's Indicator enters downward trend

The Aroon Indicator for GIFLF entered a downward trend on December 29, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 151 similar instances where the Aroon Indicator formed such a pattern. In of the 151 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for GIFLF moved below the 200-day moving average on January 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.299) is normal, around the industry mean (9.409). P/E Ratio (18.068) is within average values for comparable stocks, (24.389). Projected Growth (PEG Ratio) (0.245) is also within normal values, averaging (1.865). Dividend Yield (0.015) settles around the average of (0.025) among similar stocks. P/S Ratio (0.895) is also within normal values, averaging (3.952).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GIFLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GIFLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

View a ticker or compare two or three
GIFLF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

GIFLF paid dividends on June 07, 2021

Grifols Sa GIFLF Stock Dividends
А dividend of $0.36 per share was paid with a record date of June 07, 2021, and an ex-dividend date of June 03, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MEMX41.570.25
+0.59%
Matthews Emerging Markets Ex Chn Act ETF
SYNNF0.46N/A
N/A
Symphony International Holdings Ltd.
PDEC43.65-0.17
-0.39%
Innovator U.S. Eq Power Buffer ETF - Dec
XOVR18.11-0.29
-1.58%
ERShares Private-Public Crossover ETF
EDEN118.35-4.34
-3.54%
iShares MSCI Denmark ETF

GIFLF and Stocks

Correlation & Price change

A.I.dvisor tells us that GIFLF and GIFOF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIFLF and GIFOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFLF
1D Price
Change %
GIFLF100%
N/A
GIFOF - GIFLF
32%
Poorly correlated
N/A
GIKLY - GIFLF
27%
Poorly correlated
N/A
GRFS - GIFLF
22%
Poorly correlated
+0.21%
AMRN - GIFLF
21%
Poorly correlated
+0.37%
BAYZF - GIFLF
6%
Poorly correlated
-0.36%
More